Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matti Aapro

Showing results (11-20 of 237) with videos related to

Pageof 24
Sort By:
The Oncologist|November 25, 2004
Granisetron: an update on its clinical use in the management of nausea and vomitingMatti Aapro
Critical Reviews in Oncology/Hematology|December 16, 2017
Continuity and diversityMatti Aapro
Oncology|September 1, 2005
5-HT(3)-receptor antagonists in the management of nausea and vomiting in cancer and cancer treatmentMatti Aapro
Anti-Cancer Drugs|June 24, 2008
Controversies in endocrine treatment: effective utilization of steroidal and nonsteroidal aromatase inhibitors: now and in the future. ForwardMatti Aapro
Hematology Reports|May 16, 2012
SIOG (International Society of Geriatric Oncology) recommendations for anthracycline use in the elderlyMatti Aapro
Cancer Treatment and Research|April 21, 2005
Epidemiology of cancer and agingLodovico Balducci, Matti Aapro
Cancer|June 2, 2005
5-hydroxytryptamine type-3 receptor antagonists for chemotherapy-induced and radiotherapy-induced nausea and emesis: can we safely reduce the dose of administered agents?Matti Aapro, Peter Blower
European Journal of Cancer (Oxford, England : 1990)|February 18, 2017
Geriatric factors and outcomes in metastatic colorectal cancerDemetris Papamichael, Matti Aapro
Journal of Geriatric Oncology|February 4, 2014
Complicated and complex: helping the older patient with cancer to exit the labyrinthLodovico Balducci, Matti Aapro
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 5, 2004
Factors influencing the choice of 5-HT3-receptor antagonist antiemetics: focus on elderly cancer patientsCesare Gridelli, Matti Aapro
Pageof 24

Showing results (11-20 of 237) with videos related to

Sort By:
Pageof 24
The Oncologist|November 25, 2004
Granisetron: an update on its clinical use in the management of nausea and vomitingMatti Aapro
Critical Reviews in Oncology/Hematology|December 16, 2017
Continuity and diversityMatti Aapro
Oncology|September 1, 2005
5-HT(3)-receptor antagonists in the management of nausea and vomiting in cancer and cancer treatmentMatti Aapro
Anti-Cancer Drugs|June 24, 2008
Controversies in endocrine treatment: effective utilization of steroidal and nonsteroidal aromatase inhibitors: now and in the future. ForwardMatti Aapro
Hematology Reports|May 16, 2012
SIOG (International Society of Geriatric Oncology) recommendations for anthracycline use in the elderlyMatti Aapro
Cancer Treatment and Research|April 21, 2005
Epidemiology of cancer and agingLodovico Balducci, Matti Aapro
Cancer|June 2, 2005
5-hydroxytryptamine type-3 receptor antagonists for chemotherapy-induced and radiotherapy-induced nausea and emesis: can we safely reduce the dose of administered agents?Matti Aapro, Peter Blower
European Journal of Cancer (Oxford, England : 1990)|February 18, 2017
Geriatric factors and outcomes in metastatic colorectal cancerDemetris Papamichael, Matti Aapro
Journal of Geriatric Oncology|February 4, 2014
Complicated and complex: helping the older patient with cancer to exit the labyrinthLodovico Balducci, Matti Aapro
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 5, 2004
Factors influencing the choice of 5-HT3-receptor antagonist antiemetics: focus on elderly cancer patientsCesare Gridelli, Matti Aapro
Pageof 24